Nathan Smith

About Nathan Smith

As a public company Chief Financial Officer with over 23 years of finance leadership across high-growth private and publicly traded life sciences and healthcare organizations, I specialize in building strategic financial infrastructure, unlocking capital markets, and driving scalable growth.I’ve led teams through transformational M&A, debt refinancing, divestitures, and IPO preparation, with a deep understanding of how to align capital strategy to operational execution. From raising over $850M in equity and debt, restructuring long-term capital plans, and designing modern treasury and forecasting functions, to spearheading digital finance transformations—my focus is always to deliver sustainable financial outcomes and stakeholder value.At CareDx (NASDAQ: CDNA), I’m honored to lead finance at a company advancing cutting-edge solutions in transplant diagnostics. I’m building on a legacy of financial discipline to expand our reach, partner with clinical innovators, and deliver value to shareholders and patients alike.Throughout my career, I’ve built and scaled high-performing, cross-functional teams—growing a finance organization from 15 to over 200—while instilling diversity, accountability, and unity in execution. I believe in finance as a strategic enabler, not a back-office function—one that informs bold decisions, drives clarity, and serves both shareholders and customers.

Experience

1. Chief Financial Officer

   Inmedix Inc

   Mar 2026 — Present

   Inmedix is a medical diagnostics and biotechnology innovator advancing clinical precision in stress biology and autonomic nervous system function. Its FDA-cleared CloudHRV® platform transforms heart rate variability analytics into actionable diagnostics that help clinicians personalize patient care and improve outcomes across chronic disease populations. As Chief Financial Officer, responsible for financial strategy, capital planning, and operational scaling as the company advances commercialization and expands clinical adoption of the CloudHRV® diagnostic platform.• Leading financial strategy and operational finance for a high-growth medtech organization approaching large-scale commercialization and broader clinical adoption.• Building scalable financial infrastructure and performance management systems to support rapid expansion, reimbursement readiness, and payer-supported utilization of the CloudHRV® diagnostic platform.• Directing capital planning, forecasting, and investor engagement to align commercialization initiatives with long-term enterprise value creation.• Partnering with clinical, regulatory, and commercial leadership to integrate financial strategy with product launch timelines, reimbursement strategy, and go-to-market execution.• Developing financial models and strategic planning frameworks to support diagnostic adoption across specialty clinics, healthcare systems, and research partners.• Leading budgeting, financial reporting, and systems optimization during key FDA commercialization milestones and early-stage market rollout.• Strengthening financial governance, planning discipline, and operational controls to support institutional partnerships and long-term scaling.• Helping position Inmedix within the life sciences investor community through disciplined financial leadership, strategic planning, and commercialization readiness.

Education

• Harvard Business School

  Executive Education - Program for Leadership Development & Strategy

• Brigham Young University

  Bachelor of Business , Finance

  1999 — 2002

• University of Virginia

  Master of Science - MS, Accounting

  2002 — 2003

Skills

• Us Gaap
• Revenue Recognition
• Financial Analysis
• U.s. Generally Accepted Accounting Principles (Gaap)
• Internal Controls
• Financial Accounting
• Financial Modeling
• Financial Reporting
• U.s. Sec Filings
• Accounting
• Cpa
• General Ledger
• Sarbanes-Oxley Act
• Generally Accepted Accounting Principles (Gaap)
• Auditing
• Sec Filings
• Gaap
• Internal Audit